ADENTRA Inc. (TSX:ADEN)
| Market Cap | 799.62M +24.3% |
| Revenue (ttm) | 3.17B +3.5% |
| Net Income | 92.62M +66.2% |
| EPS | 3.70 +65.2% |
| Shares Out | 24.25M |
| PE Ratio | 8.92 |
| Forward PE | 9.63 |
| Dividend | 0.64 (1.91%) |
| Ex-Dividend Date | Jul 20, 2026 |
| Volume | 791,713 |
| Open | 33.38 |
| Previous Close | 33.44 |
| Day's Range | 32.97 - 33.58 |
| 52-Week Range | 25.55 - 41.20 |
| Beta | 1.33 |
| Analysts | Buy |
| Price Target | 49.60 (+50.39%) |
| Earnings Date | May 5, 2026 |
About ADENTRA
ADENTRA Inc. engages in the wholesale distribution of architectural building products to the residential, repair and remodel, and commercial construction markets in Canada and the United States. It offers doors, decorative surfaces, mouldings, stair parts, hardwood lumber, hardwood plywood, composite panels, outdoor living, boards, roofing, and other building products to industrial manufacturers, home builder distribution yards, and home centers. The company was formerly known as Hardwoods Distribution Inc. and changed its name to ADENTRA Inc. ... [Read more]
Financial Performance
In 2025, ADENTRA's revenue was $2.25 billion, an increase of 2.98% compared to the previous year's $2.18 billion. Earnings were $68.43 million, an increase of 47.23%.
Financial numbers in USD Financial StatementsNews
ADENTRA Earnings Call Transcript: Q1 2026
Q1 2026 saw 3.7% organic sales growth and resilient margins despite macro headwinds, with strong U.S. performance offsetting Canadian softness. Strategic focus on AI, supply chain, and disciplined M&A supports long-term value, while cost control and working capital efficiency improved leverage and cash flow.
ADENTRA Earnings release: Q1 2026
ADENTRA released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
ADENTRA Registration statement: Q1 2026
ADENTRA filed a registration statement on May 6, 2026, providing details about a securities offering with the SEC.
ADENTRA Registration statement: Q1 2026
ADENTRA filed a registration statement on May 6, 2026, providing details about a securities offering with the SEC.
ADENTRA Transcript: AGM 2026
The meeting confirmed quorum, elected nine directors, and reappointed KPMG LLP as auditors with strong shareholder support. No questions were received from shareholders, and final voting results will be posted on SEDAR+.
Adentra price target lowered to C$45 from C$46 at Scotiabank
Scotiabank lowered the firm’s price target on Adentra (HDIUF) to C$45 from C$46 and keeps an Outperform rating on the shares.
Adentra price target raised to C$51 from C$49.50 at Stifel
Stifel raised the firm’s price target on Adentra (HDIUF) to C$51 from C$49.50 and keeps a Buy rating on the shares.
Adentra price target lowered to C$42 from C$44 at CIBC
CIBC lowered the firm’s price target on Adentra (HDIUF) to C$42 from C$44 and keeps an Outperformer rating on the shares.
Adentra price target lowered to C$49.50 from C$51 at Stifel
Stifel lowered the firm’s price target on Adentra (HDIUF) to C$49.50 from C$51 and keeps a Buy rating on the shares.
ADENTRA Earnings Call Transcript: Q4 2025
Sales grew 3% to CAD 2.25B in 2025 with strong cash flow and margin discipline, despite softer volumes and a muted construction market. Q4 gross margin rose to 22.1%, and leverage improved to 2.2x, positioning the company for renewed M&A activity and continued shareholder returns.
ADENTRA Earnings release: Q4 2025
ADENTRA released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
ADENTRA Slides: Investor presentation
ADENTRA has posted slides in relation to its latest quarterly earnings report, which was published on March 11, 2026.
Adentra price target raised to C$46 from C$41 at Scotiabank
Scotiabank raised the firm’s price target on Adentra (HDIUF) to C$46 from C$41 and keeps an Outperform rating on the shares.
Adentra downgraded to Speculative Buy from Buy at Cormark
Cormark downgraded Adentra (HDIUF) to Speculative Buy from Buy with a C$50 price target
Adentra price target raised to C$47 from C$45 at Stifel
Stifel raised the firm’s price target on Adentra (HDIUF) to C$47 from C$45 and keeps a Buy rating on the shares.
ADENTRA Earnings Call Transcript: Q3 2025
Q3 saw 4% sales growth and stable margins despite a soft construction market, with strong cash flow and continued shareholder returns. Tariff exposure is managed via price pass-through, and further deleveraging is expected as inventory is reduced.
ADENTRA Earnings release: Q3 2025
ADENTRA released its Q3 2025 earnings on November 10, 2025, summarizing the period's financial results.
ADENTRA Slides: Investor presentation
ADENTRA has posted slides in relation to its latest quarterly earnings report, which was published on November 9, 2025.
Adentra price target raised to C$40 from C$39 at Scotiabank
Scotiabank raised the firm’s price target on Adentra (HDIUF) to C$40 from C$39 and keeps an Outperform rating on the shares.
Adentra price target lowered to C$45 from C$51 at Stifel
Stifel lowered the firm’s price target on Adentra (HDIUF) to C$45 from C$51 and keeps a Buy rating on the shares.
Adentra price target raised to C$42 from C$37 at CIBC
CIBC raised the firm’s price target on Adentra (HDIUF) to C$42 from C$37 and keeps an Outperformer rating on the shares.
Adentra price target raised to C$42.50 from C$41 at National Bank
National Bank analyst Zachary Evershed raised the firm’s price target on Adentra (HDIUF) to C$42.50 from C$41 and keeps an Outperform rating on the shares.
Adentra price target raised to C$39 from C$35 at Scotiabank
Scotiabank raised the firm’s price target on Adentra (HDIUF) to C$39 from C$35 and keeps an Outperform rating on the shares.
Adentra price target raised to C$51 from C$44 at Stifel
Stifel raised the firm’s price target on Adentra (HDIUF) to C$51 from C$44 and keeps a Buy rating on the shares.
ADENTRA Earnings Call Transcript: Q2 2025
Q2 sales rose 8.7% to $597M, driven by Wolf Distributing, with gross margin and EBITDA improving year-over-year. Inventory and leverage are expected to improve in H2, while tariff exposure and trade uncertainty remain key risks.